Регистрация | Вход в службу | FAQ      [?] 

Haemophilia

Статьи последних нескольких выпусков журнала Haemophilia © Blackwell Publishing
  • Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders: A UNITED KINGDOM HAEMOPHILIA CENTER DOCTORS' ORGANISATION (UKHCDO) GUIDELINE APPROVED BY THE BRITISH COMMITTEE FOR STANDARDS IN HAEMATOLOGY
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 671-684.
    by D Keeling, C Tait, M Makris
  • Type 1 von Willebrand disease: application of emerging data to clinical practice
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 685-696.
    by PW Collins, AM Cumming, AC Goodeve, D Lillicrap
  • Coping with the HIV epidemic 19822007: 25-year outcomes of the Hershey Haemophilia Cohort
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 697-702.
    by ME Eyster
  • The impact of severe haemophilia on the social status and quality of life among Austrian haemophiliacs
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 703-708.
    by HK Hartl, S Reitter, U Eidher, H Ramschak, C Ay, I Pabinger
  • Molecular analysis of F8 in Lebanese haemophilia A patients: novel mutations and phenotypegenotype correlation
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 709-716.
    by Djambas Khayat, , N Salem, E Chouery, S Corbani, I Moix, E Nicolas, MA Morris, DE Moerloose, , A Megarbane
  • Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 717-722.
    by PV Jenkins, H Egan, C Keenan, E Oshea, OP Smith, B Nolan, B White, J Odonnell
  • Why does the mutation G17736AVal107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 723-728.
    by KE Knobe, E Sjorin, RCR Ljung
  • Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 729-735.
    by J Boekhorst, GR Lari, R Doiron, JM Costa, IRO Novakova, FA Ala, JM Lavergne, VAN Heerde,
  • Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 736-742.
    by H Dehmel, S Werwitzke, A Trummer, A Ganser, A Tiede
  • Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 743-752.
    by N Risebrough, P Oh, V Blanchette, J Curtin, J Hitzler, BM Feldman
  • Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 753-762.
    by M Herbertson, G Kenet
  • Successful surgical haemostasis in patients with von Willebrand disease with KoateDVI
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 763-767.
    by A Viswabandya, V Mathews, B George, SC Nair, S Baidya, JJ Mammen, M Chandy, A Srivastava
  • Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 768-774.
    by YC Chen, TY Chao, SN Cheng, SH Hu, JY Liu
  • Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 775-781.
    by L O'Connel, , AF Riddell, G Pascoe, DJ Perry, CA Lee
  • Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 782-786.
    by T Livnat, U Martinowitz, A Zivelin, U Seligsohn
  • The spectrum of the factor 8 (F8) defects in Taiwanese patients with haemophilia A
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 787-795.
    by GC Ma, SP Chang, M Chen, SJ Kuo, CS Chang, MC Shen
  • Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 796-803.
    by V Sanna, F Zarrilli, P Nardiello, O D'Argeni, , A Rocino, A Coppola, DI Minno, , G Castaldo
  • Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 804-809.
    by N Hakobyan, C Enockson, AA Cole, DR Sumner, LA Valentino
  • Hepatitis C: serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringa, Maringa PR Brazil
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 810-815.
    by MRMN Ferreira, MVC Lonardoni, DA Bertolini
  • Evidence of occult HCV genotypes in haemophilic individuals with unapparent HCV mixed infections
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 816-822.
    by C Parodi, A Culasso, N Aloisi, G Garcia, M Baston, M Corti, RP Bianco, R Campos, BR Ares, P Bare
  • Domiciliary application of CryoCuff in severe haemophilia: qualitative questionnaire and clinical audit
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 823-827.
    by G Dyoun,
  • Total knee arthroplasty for severe haemophilic arthropathy: long-term experience in Taiwan
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 828-834.
    by CC Chiang, PQ Chen, MC Shen, W Tsai
  • Association von Willebrands disease and nevoid basal cell carcinoma syndrome (Gorlin syndrome)
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 835-837.
    by L Gallego, L Junquera
  • Cranial haemophilic pseudotumour: conservative management of an extremely rare complication with factor replacement alone
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 838-840.
    by T Zafar, W Ali, M Winter
  • Successful management of Mallory-Weiss syndrome in a haemophilia A patient with inhibitor by recombinant activated factor VII
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 841-843.
    by Y Uchida, Y Sakurai, K Ogiwara, T Chiyonobu, B Higuchi, I Tanaka, M Shima, A Yoshioka
  • Severe hyponatraemia after DDAVP stimulation test in an adult patient
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 844-845.
    by D Posthouwer, JH Rommes, VAN Bemmel, , CG Schaar
  • Female haemophilia A caused by skewed X inactivation
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 846-848.
    by KE Knobe, E Sjorin, MJ Soller, H Liljebjorn, RCR Ljung
  • An IKBKG, and not a G6PD, short tandem repeat marker is used in indirect diagnosis of haemophilia A
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 849-850.
    by FB Machado, E Medina-Acosta
  • Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 851-852.
    by M Karimi, R Shafieian
  • Recurrent ovarian haemorrhage in a girl with congenital factor X deficiency
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 853-855.
    by V Dadhwal, D Deka, B Ghosh, S Mittal
  • Acquired von Willebrand syndrome
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 856-858.
    by MT Alvarez, V Jimenez-Yuste, J Gracia, M Quintana, F Hernandez-Navarro
  • Therapeutic shoulder arthroscopy in patients with clotting disorders
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 859-861.
    by JMC Thomas, EG Tuddenham, PM Ahrens
  • The medial plica syndrome can mimic recurring acute haemarthroses
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 862-862.
    by R Lipton, J Roofeh
  • Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 863-865.
    by S Pasa, A Altintas, T Cil, R Danis, M Subasi, O Ayyildiz, E Muftuoglu
  • The compatible MRI scoring system for staging of haemophilic arthropathy
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 866-867.
    by N Fotiadis, I Ekonomou, A Haritanti, I Tsatra, M Athanassiou-Metaxa, AS Dimitriadis
  • The non-ionic surfactant poloxamer P188 does not prevent blood-induced cartilage damage
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 868-870.
    by NWD Jansen, G Roosendaal, JWJ Bijlsma, M Theobald, FPJG Lafeber
  • New haemostatic textile stopped refractory bleeding in an aplastic anaemia patient
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 871-872.
    by SA Schumacher, TH Fischer, CJ Smith
  • Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report
    Haemophilia, Vol. 14, No. 4. (July 2008), pp. 873-875.
    by M Morfini, P Laguna, C Leissinger
  • Bleeding scores in inherited bleeding disorders: clinical or research tools?
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 415-422.
    by A Tosetto, G Castaman, F Rodeghiero
  • Hypothyroidism and acquired von Willebrands syndrome: a systematic review
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 423-433.
    by E Manfredi, Van B Zaane, VEA Gerdes, DPM Brandjes, A Squizzato
  • Paracetamolacetaminophen usage in haemophilia: more caution needed?
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 434-435.
    by VEEN Van, , DC Gleeson, M Makris
  • Integrated specialty service readiness in health reform: connections in haemophilia comprehensive care
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 436-443.
    by AM Pritchard, D Page
  • Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 444-453.
    by A Iorio, E Oliovecchio, M Morfini, PM Mannucci
  • Physicians preferences towards coagulation factor concentrates in the treatment of Haemophilia with inhibitors: a discrete choice experiment
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 454-465.
    by WC Lee, AV Joshi, S Woolford, M Sumner, M Brown, N Hadker, CL Pashos
  • Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 466-475.
    by WK Hoots, LS Ebbesen, BA Konkle, Auerswald, HR Roberts, J Weatherall, JM Ferran, RCR Ljung
  • Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 476-483.
    by R Yatuv, I Dayan, L Carmel-Goren, M Robinson, I Aviv, M Goldenberg-Furmanov, M Baru
  • Spectrum of factor VIII mutations in Arab patients with severe haemophilia A
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 484-488.
    by KK Abu-Amero, A Hellani, M Al-Mahed, I Al-Sheikh
  • Application of intron 9 and intron 25 dinucleotide repeats of the factor VIII gene for carrier diagnosis in haemophilia A
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 489-493.
    by A Vencesla, M Baena, TAIE Fares, , M Cornet, M Baiget, EF Tizzano
  • Septic arthritis in males with haemophilia
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 494-503.
    by AA Ashrani, NS Key, Michael Soucie, , N Duffy, A Forsyth, S Geraghty
  • Inter- and intra-observer reliability of radiographic scores commonly used for the evaluation of haemophilic arthropathy
    Haemophilia, Vol. 14, No. 3. (May 2008), pp. 504-512.
    by M Silva, JV Luck, D Quon, CR Young, DM Chin, E Ebramzadeh, YJ Fong
    • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/journal/bsc-haem

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.